Anaplastic Large Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Anaplastic Large Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating brentuximab vedotin in combination with bendamustine for Hodgkin lymphoma and anaplastic large cell lymphoma comp…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL) [Phase 1]
Phase 1 study evaluating the combination of alectinib and duvelisib in ALK-positive anaplastic large cell lymphoma (ALK+ ALCL) is currently …
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma [Phase 1, Phase 2]
Clinical trial update for AUTO4 in TRBC1-positive T-cell lymphomas shows Phase 1/2 results with the study terminated and results posted.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers [Phase 1]
A Phase 1 safety study of PF-08046045/SGN-35T sponsored by Seagen has been terminated in adults with advanced lymphomas and Hodgkin disease.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Combination With Romidepsin [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pembrolizumab in combination with romidepsin for recurrent or refractory T-cell lymphomas; the study i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial update indicates brigatinib is currently recruiting pediatric and young adult patients with ALK-positive Anaplast…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas [Phase 1, Phase 2]
This is a completed Phase 1/2 clinical trial from MD Anderson evaluating AFM13 and AFM13-NK in patients with recurrent or refractory CD30-po…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating dose-adjusted EPOCH chemotherapy plus Rituximab in previously untreated aggressive non-Hodgkin lymphoma has complet…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies [Phase 1]
Phase 1 trial evaluating anti-CD7 CAR-T cell therapy for relapsed/refractory CD7-positive T-cell malignancies has completed, assessing safet…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Vinorelbine for Recurrent ALCL-2017 [Phase 2]
Phase 2 trial evaluating vinorelbine for recurrent anaplastic large cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas [Phase 1]
Phase 1 trial update evaluating the combination of romidepsin and parsaclisib for relapsed or refractory T-cell lymphomas; the study status …
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas [Phase 2]
Phase 2 trial evaluating brentuximab vedotin in relapsed or refractory EBV-positive, CD30-positive lymphomas; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study of pembrolizumab plus pralatrexate in relapsed or refractory peripheral T-cell lymphomas…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of romidepsin and lenalidomide in previously untreated peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma [Phase 1]
Phase 1 trial evaluating crizotinib with combination chemotherapy in younger patients with relapsed or refractory solid tumors or anaplastic…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: CREATE: Cross-tumoral Phase 2 With Crizotinib [Phase 2]
Phase 2 cross-tumor trial evaluating crizotinib in multiple locally advanced or metastatic cancers; study completed.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating retreatment with brentuximab vedotin in classic Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma h…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating venetoclax with romidepsin in recurrent or refractory mature T-cell lymphoma and related NK/T-cell non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL [Phase 2]
Phase 2 study of AT13387 (Onalespib) in ALK+ anaplastic large cell lymphoma, mantle cell lymphoma, and BCL-6+ diffuse large B-cell lymphoma …
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies [Phase 1]
Phase 1 trial evaluating interleukin-15 in combination with avelumab in relapsed/refractory mature T-cell malignancies completed; results po…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Vinorelbine for Recurrent ACLC [Phase 2]
Phase 2 clinical trial of vinorelbine for recurrent anaplastic large cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating Brentuximab Vedotin or Crizotinib in combination with chemotherapy for newly diagnosed Anaplastic Large Cell Lymp…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms [Phase 2]
Phase 2 study of BGB-A317 (tislelizumab) in adults with relapsed or refractory mature T- and NK-cell neoplasms has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating Brentuximab Vedotin in combination with Bendamustine for Hodgkin lymphoma and anaplastic large cell lymphoma. The…
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma [Phase 1, Phase 2]
Clinical trial investigating crizotinib in children with relapsed or refractory solid tumors and anaplastic large cell lymphoma has complete…